The community hospital on the Eastside of Seattle saw its rating on the bonds decrease from “A2” to “Baa1.” The outlook remains negative.
While some of the labor pressures are expected to moderate, margins will remain weak compared with historical levels even as Overlake institutes a number of cash-preservation strategies, Moody’s said.
“The downgrade to Baa1 reflects Moody’s expectations that Overlake’s margins will remain below historically strong levels through at least mid-fiscal 2024,” Moody’s said in the research note.
The hospital, which also operates several outpatient clinics and physician offices in its service area, has $295 million of outstanding debt.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
